awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q54518660-1F50DFD4-9F61-45C3-8B2A-749284A9F359
Q54518660-1F50DFD4-9F61-45C3-8B2A-749284A9F359
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54518660-1F50DFD4-9F61-45C3-8B2A-749284A9F359
Pembrolizumab KEYNOTE-001: an adaptive study leading to accelerated approval for two indications and a companion diagnostic.
P2860
Q54518660-1F50DFD4-9F61-45C3-8B2A-749284A9F359
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54518660-1F50DFD4-9F61-45C3-8B2A-749284A9F359
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0ccc5ea01b3c22ec2551f310d63fd6581f1b7249
P2860
Pembrolizumab: A Review in Advanced Melanoma.